The COVID-19 and Cancer Consortium (CCC19)

The COVID-19 and Cancer Consortium


Eligibility

We are collecting reports on adult patients (18 and older) with a current or historical invasive solid or hematologic malignancy who have been diagnosed with COVID-19, with or without laboratory confirmation of SARS-CoV-2 infection. Reporting is anonymous and all reported data must be de-identified. This study is registered with ClinicalTrials.gov, NCT04354701, and is now closed to new accruals.

Healthcare providers (or their proxies) from the United States, the European Union (EU), Argentina, Canada, Mexico, and the United Kingdom (UK) are eligible to report cases.

About Us

CCC19 is a consortium of over 120 cancer centers and other organizations who have come together to collect data about patients with cancer who have been diagnosed with COVID-19.

The driving goal of the CCC19 consortium is to collect and disseminate prospective, granular, uniformly organized information on people with cancer who are diagnosed with COVID-19 – at scale and as rapidly as possible.






List of Participating Institutions

as of April 20, 2022

(*) NCI-Designated Comprehensive Cancer Center | (**) NCI-Designated Cancer Center
Founding Institutions are in bold.


Platinum Tier Institutions

These sites are recognized for outstanding overall and ongoing contributions to the CCC19 registry.

  • Brown University/Lifespan Cancer Institute
  • Columbia University/Herbert Irving Comprehensive Cancer Center (**)
  • Dana-Farber Cancer Institute (**)
  • Hartford HealthCare Cancer Institute
  • Henry Ford Cancer Institute, Henry Ford Hospital
  • Mount Auburn Hospital
  • Roswell Park Comprehensive Cancer Center (**)
  • Segal Cancer Centre, Jewish General Hospital, McGill University
  • Instituto Nacional de Cancerología (**)
  • Loma Linda University Cancer Center
  • The University of Kansas Cancer Center(*)
  • University of Michigan/Rogel Cancer Center (**)
  • University of California San Diego/Moores Cancer Center (**)
  • University of Cincinnati Cancer Center
  • Virtua Health

Gold Tier Institutions

These sites are recognized for substantial overall and ongoing contributions to the CCC19 registry.

  • Advocate Aurora Health
  • Montefiore Einstein Comprehensive Cancer Center (*)
  • Cleveland Clinic (**)
  • Duke University Medical Center/Duke Cancer Institute (**)
  • Emory University/Winship Cancer Institute (**)
  • George Washington University
  • Loyola University Medical Center
  • Mayo Clinic (**)
  • McGill University Health Centre
  • Medical College of Wisconsin
  • Mount Sinai/Tisch Cancer Institute (*)
  • Northwest Medical Specialties
  • Oregon Health & Sciences University/Knight Cancer Institute
  • Penn State Cancer Institute (**)
  • Penn State Health St. Joseph Cancer Center
  • Stamford Hospital/Carl & Dorothy Bennett Cancer Center
  • St. Elizabeth Healthcare
  • Tallahassee Memorial Healthcare
  • Thomas Jefferson University/Sidney Kimmel Cancer Center (*)
  • University of California, San Francisco/Helen Diller Family Comprehensive Cancer Center (**)
  • University of Illinois at Chicago
  • University of Kentucky/Markey Cancer Center (*)
  • University of Minnesota/Masonic Cancer Center (**)
  • UPMC Western Maryland
  • UT Health San Antonio MD Anderson Cancer Center/Mays Cancer Center (*)
  • Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center (**)

Silver Tier Institutions

These sites are recognized for overall and/or ongoing contributions to the CCC19 registry.

  • Banner MD Anderson Cancer Center
  • Kaiser Permanente Northwest
  • Lewis Cancer & Research Pavilion @ St. Joseph’s/Candler
  • LSU Health Sciences Center – New Orleans/Stanley S. Scott Cancer Center
  • Massachusetts General Hospital (**)
  • Medical University of South Carolina/Hollings Cancer Center (*)
  • Missouri Baptist Medical Center
  • Moffitt Cancer Center (**)
  • The Ohio State University Comprehensive Cancer Center (**)
  • Providence Cancer Institute
  • Rutgers Cancer Institute of New Jersey at Rutgers Biomedical and Health Sciences (**)
  • Stanford University/Stanford Cancer Institute (**)
  • ThedaCare Cancer Care
  • Tufts Medical Center
  • University of Hawai’i Cancer Center (*)
  • University of Iowa/Holden Comprehensive Cancer Center (**)
  • University of North Carolina/Lineberger Comprehensive Cancer Center (**)

Bronze Tier Institutions

These sites are recognized for contributions to the CCC19 registry.

  • Baptist Cancer Center
  • Baylor College of Medicine/Dan L. Duncan Comprehensive Cancer Center (**)
  • BC Cancer
  • Beth Israel Deaconess Medical Center (**)
  • Case Comprehensive Cancer Center at Case Western Reserve University/University Hospitals, Cleveland (**)
  • Centre Hospitalier de l'Université de Montréal
  • Centro Médico ABC
  • Einstein Healthcare Network
  • Geisinger Health System
  • Gundersen Health System
  • Houston Methodist Cancer Center
  • Inova Schar Cancer Institute
  • Intermountain Healthcare
  • Memorial Sloan Kettering Cancer Center(**)
  • Mount Carmel Health System
  • Northwestern University/Lurie Cancer Center (**)
  • Thompson Cancer Survival Center
  • Tripler Army Medical Center
  • University of California at Davis/UC Davis Comprehensive Cancer Center (**)
  • University of Colorado Cancer Center (**)
  • University of Florida Health Cancer Center
  • University of Miami/Sylvester Comprehensive Cancer Center (*)
  • University of Washington and Fred Hutchinson Cancer Center (**)
  • Virginia Mason Cancer Institute
  • Wake Forest Baptist Comprehensive Cancer Center (**)
  • Washington University in St. Louis/Siteman Cancer Center (**)
  • Wayne State University/Barbara Ann Karmanos Cancer Institute (**)
  • Weill Cornell Medicine/Meyer Cancer Center
  • WellSpan Health
  • Wentworth-Douglass Hospital
  • Willis-Knighton Cancer Center
  • Yale New Haven Health/Smilow Cancer Hospital (**)



Unlisted Institutions

These sites have either not yet contributed to the CCC19 registry or have opted out of public recognition.

  • Barrow Neurological Institute
  • Boston Medical Center
  • City of Hope Comprehensive Cancer Center (**)
  • Cook County Hospital
  • Georgetown University/Georgetown Lombardi Comprehensive Cancer Center (**)
  • Hamilton Health Sciences
  • HCA Houston Healthcare North Cypress
  • Hospital General de México
  • Hospital Regional de Alta Especialidad de Ixtapaluca
  • Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (**)
  • Kent Hospital/Care New England Medical Group
  • MD Anderson Cancer Center (**)
  • MD Anderson Cancer Center at Cooper
  • Meharry Medical College
  • Michigan Center of Medical Research
  • NYU Langone Health/Perlmutter Cancer Center (**)
  • Parkview Cancer Institute/Parkview Research Center
  • Renown Regional Medical Center
  • Rush University Medical Center
  • SUNY Downstate Health Sciences University
  • UCLA Jonsson Comprehensive Cancer Center (**)
  • University of Alabama/O'Neal Comprehensive Cancer Center (**)
  • University of Arkansas Medical Sciences
  • University of Chicago Comprehensive Cancer Center (**)
  • University of Connecticut
  • University of Louisville/James Graham Brown Cancer Center
  • University of Maryland/Marlene and Stewart Greenebaum Comprehensive Cancer Center (**)
  • University of Mississippi Medical Center
  • University of Nebraska Medical Center/Fred and Pamela Buffett Cancer Center (*)
  • University of Rochester Medical Center
  • University of Texas Southwestern Medical Center/Harold C. Simmons Comprehensive Cancer Center (**)
  • University of Utah/Huntsman Cancer Institute (**)
  • University of Wisconsin/Carbone Cancer Center (**)
  • Vidant Medical Center, East Carolina University


Our Partners

Count Me In Hematology/Oncology Pharmacy Association Oncology Nursing Society Ovarian Cancer Research Alliance Kidney Cancer Association Patient Empowerment Network Reboot Rx Terasaki Institute
HemOnc Stupid Cancer


Socials


CCC-19 is on LinkedIn, YouTube, and Twitter.

Downloads






Become a Collaborator

Please send us a message if you have a question or would like to participate in the COVID-19 and Cancer Consortium.